Local Coverage Determination (LCD)

Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies

L35751

Expand All | Collapse All
Proposed LCD
Proposed LCDs are works in progress that are available on the Medicare Coverage Database site for public review. Proposed LCDs are not necessarily a reflection of the current policies or practices of the contractor.

Document Note

Note History

Contractor Information

LCD Information

Document Information

Source LCD ID
N/A
LCD ID
L35751
Original ICD-9 LCD ID
Not Applicable
LCD Title
Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies
Proposed LCD in Comment Period
N/A
Source Proposed LCD
DL35751
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 11/30/2023
Revision Ending Date
N/A
Retirement Date
N/A
Notice Period Start Date
07/01/2015
Notice Period End Date
08/15/2015
AMA CPT / ADA CDT / AHA NUBC Copyright Statement

CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2023, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Issue

Issue Description

Review completed with no change in coverage.

Issue - Explanation of Change Between Proposed LCD and Final LCD

CMS National Coverage Policy

Title XVIII of the Social Security Act section 1833 (e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.

Title XVIII of the Social Security Act section 1862 (a) (1) (A) allows coverage and payment of those items or services that are considered to be medically reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

Title XVIII of the Social Security Act section 1862 (a) (1) (D) excludes Medicare payment for any expenses incurred for items or services that are investigational or experimental.

Title XVIII of the Social Security Act section 1862 (a) (7) excludes routine physical examinations and services from Medicare coverage.

42 CFR, Section 410.32 Diagnosis x-ray tests, diagnostic laboratory tests, and other diagnostic indicates that diagnostic tests may only be ordered by the treating physician (or other treating practitioner acting within the scope of his or her license and Medicare requirements) who furnishes a consultation or treats a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary’s specific medical problem. Tests not ordered by the physician or other qualified non-physician provider who is treating the patient are not reasonable and necessary (see 42 CFR 411.15(k) (1).

42 CFR, Section 410.32 (b) Diagnostic x-ray and other diagnostic tests. (1) Basic rule. .. all diagnostic x-ray and other diagnostic tests covered under section 1861(s)(3) of the Act and payable under the physician fee schedule must be furnished under the appropriate level of supervision by a physician as defined in section 1861® of the Act. Services furnished without the required level of supervision are not reasonable and necessary. (see 42 CFR 411.15(k)(1)).

CMS Pub. 100-02 Medicare Benefit Policy Manual, Chapter 11 – End Stage Renal Disease, Section 40 – Other Services.
Chapter 15 – Covered Medical and Other Health Services, Section
80 – Requirements for Diagnostic X-Ray, Diagnostic Laboratory, and Other Diagnostic Tests.

CMS Pub 100-03 Medicare National Coverage Determinations (NCD) Manual, Chapter 1 – Coverage Determinations Part 1, Section
20.14 – Plethysmography and
Part 4, Sections 220.5 - Ultrasound Diagnostic Procedures,

CMS Pub 100-04 Medicare Claims Processing Manual, Chapter 7 – SNF Part B Billing (Including Inpatient Part B and Outpatient Fee Schedule), Section
50 – Billing Part B Radiology Services and Other Diagnostic Procedures;
Chapter 8 - Outpatient ESRD Hospital, Independent Facility, and Physician/ Supplier Claims, Sections 140 – Monthly Capitation Payment Methods for Physicians’ Services Furnished to Patients on Maintenance Dialysis. A. – Services Included in Monthly Capitation Payment and
180 - Noninvasive Studies for ESRD Patients - Facility and Physician Services;
Chapter 13 – Radiology Services and Other Diagnostic Procedures, Sections –
10.1 Billing Part B Radiology Services and Other Diagnostic Procedures and
20 – Payment Conditions for Radiology Services; and
Chapter 16 – Laboratory Services, Section
40.2 – Payment Limit for Purchased Services, and
Chapter 23 – Fee Schedule Administration and Coding Requirements, Addendum – MPFSDB Record Layouts.

CMS Pub 100-08, Medicare Program Integrity Manual, Chapter 13 – Local Coverage Determinations, Section 13.5.1 – Reasonable and Necessary Provisions in LCDs.

CMS Publication 100-09, Medicare Contractor Beneficiary and Provider Communications Manual, Chapter 5 - Correct Coding Initiative.

Coverage Guidance

Coverage Indications, Limitations, and/or Medical Necessity

Overview
Non-invasive peripheral venous vascular studies utilize ultrasonic Doppler and physiologic studies to assess the irregularities in blood flow in the venous system. Noninvasive peripheral venous vascular studies include the patient care required to perform the studies, supervision of the studies, and interpretation of study results, with copies for patient records of test results and analysis of all data, including bi-directional vascular flow or imaging when provided.

Diagnostic tests must be ordered by the physician who is treating the beneficiary and use the result in the management of the beneficiary’s specific medical problem. Services are deemed medically necessary when all of the following conditions are met:

  1. Signs/symptoms of ischemia or altered blood flow are present;
  2. The information is necessary for appropriate medical and/or surgical management;
  3. The test is not redundant of other diagnostic procedures that must be performed.

Definitions:
Duplex Scans: Duplex combines Doppler and conventional ultrasound, allowing the structure of blood vessels, how the blood is flowing through the vessels, and whether there is any obstruction in the vessels to be seen. Color Doppler produces a picture of the blood vessel, and a computer converts the Doppler sounds into colors overlaid on the image, representing information about the speed and direction of blood flow. Using spectral Doppler analysis, the duplex scan images provide anatomic and hemodynamic information, identifying the plaque, occlusions and incompetent veins. Duplex scans are in real-time.

Physiologic Studies: Functional measurement procedures which include Doppler ultrasound studies, blood pressure and physiologic waveforms, segmental pressure measurements, blood pressure measurements, transcutaneous oxygen tension measurements, exercise testing, and/or plethysmography. These studies do not involve imaging.

Doppler Ultrasound uses reflected sound waves called physiologic waveforms to evaluate the blood as it flows through a vein. The waveforms bounce off blood cells in a motion that causes a change in the pitch of the sound, called the Doppler effect. These can be measured at a single level, or at segmental (various) limb levels. An audible sound is created and recorded by either an analog recorder or spectral analyzer. Spectral analysis separates the signal into individual components and assigns a relative importance. If there is no blood flow, the pitch does not change. The receiver detects the shift.

Exercise testing can be used to analyze the functional significance of vascular disease by reassessing the blood pressure with the Doppler stethoscope after completion of an appropriate amount of stress testing.

Plethysmography is a measurement of the volume of an organ or limb section, or flow rate, in response to the inflation and deflation of a BP cuff. Volume measurement procedures include air, impedance or strain gauge methods.

I Peripheral Venous Vascular Studies
Indications for peripheral venous vascular examinations are separated into three major categories: deep vein thrombosis (DVT), chronic venous insufficiency, and vein mapping. Studies, which are medically necessary to determine subsequent treatment, are covered if the patient is a candidate for anticoagulation, thrombolysis or invasive therapeutic procedures.

A.    Deep Vein Thrombosis (DVT)
Indications: 
The signs and symptoms of DVT are relatively non-specific; and due to the risk associated with pulmonary embolism (PE), objective testing is allowed in patients who are candidates for anticoagulation or invasive therapeutic procedures for the following conditions:

  1. Clinical signs and/or symptoms of DVT including edema, tenderness, inflammation, and/or erythema.
  2. Clinical signs and/or symptoms of pulmonary embolism (PE) including hemoptysis, chest pain, and/or dyspnea.
  3. Unexplained lower extremity edema status, post major surgical procedures, trauma, other or progressive illness/condition; surveillance following high-risk surgical       procedures, such as orthopedic or pelvic. Individual consideration will be given to surveillance of patients on prolonged bed rest (e.g., due to neurologic, condition / procedures, congestive heart failure, and paradoxical emboli). In general, surveillance is not necessary when effective antithrombotic measures (e.g., anticoagulants, alternating pressure devices) are being used.  However, it may be necessary in some patients prior to applying alternating pressure devices or compression dressings under appropriate clinical circumstances.
  4. Unexplained lower extremity pain, excluding pain of skeletal origin.
  5. Bilateral limb edema is rarely an indicator for medical necessity in the presence of signs and symptoms of heart failure, exogenous obesity, and/or arthritis.

B. Chronic Venous Insufficiency
Indications:
Chronic venous insufficiency may be divided into three categories: primary varicose veins, post-thrombotic (post-phlebitic) syndrome, and recurrent deep vein thrombosis. Peripheral vascular studies may be indicated in patients with:

  1. Ulceration suspected to be secondary to venous insufficiency. These tests may be indicated to confirm this diagnosis by documenting venous valvular incompetence prior to invasive therapeutic treatment.
  2. Varicose veins by themselves do not indicate medical necessity, but medical necessity may be indicated when they are accompanied by significant pain or stasis dermatitis. It is not medically necessary to study asymptomatic primary varicose veins (See WPS policy L34536, Treatment of Varicose Veins of the Lower Extremities).
  3. Superficial thrombophlebitis involving the proximal thigh, to investigate whether there was thrombus at the saphenofemoral junction that would demand either anticoagulation or surgical ligation.
  4. Evaluation is medically necessary in patients with symptoms of recurrent DVT or in patients prior to compression therapy to exclude superimposed acute DVT which may be at risk for embolization with such therapy.

C. Venous Mapping
Indications:
Vein mapping is considered medically reasonable and necessary when the patient’s clinical evaluation indicates one of the following:

  1. Previous partial harvest of the vein.
  2. Previous thrombophlebitis or DVT in the leg.
  3. Severe varicose veins.
  4. Previous history of vein stripping, ligation, or sclerotherapy.
  5. Obesity to the degree it interferes with clinical determination.
  6. Other indications must be clearly supported by medical documentation.
  7. Vein mapping may be performed prior to creating a dialysis fistula. See section III in this policy on vessel mapping of vessels for hemodialysis.
  8. Mapping the saphenous veins prior to scheduled revascularization procedures is covered when it is expected that an autologous vein will be used, but only if there is uncertainty regarding the availability of a suitable vein for bypass

Limitations:

  1. Vein mapping as a routine preoperative study is not covered.
  2. Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study is indicated for the preoperative examination of potential harvest vein grafts to be utilized during bypass surgery. This is a covered service only when the results of the study are necessary to locate suitable graft vessels. The need for the bypass surgery must be determined prior to the performance of the test.

II. Hemodialysis Access Studies
Medicare considers a Doppler flow study medically necessary when the patient’s dialysis access site manifests signs or symptoms associated with vascular compromise, and when the results of this test are necessary to determine the clinical course of treatment. For examples supporting the medical necessity for Doppler flow studies see: CMS Pub 100-02 Medicare Benefit Policy Manual, Chapter 11-End Stage Renal Disease (ESRD), Section 40, H.

III. Vessel Mapping of Vessels for Hemodialysis Access
Indications:
Vessel mapping of vessels for hemodialysis access is considered for Medicare payment when it is performed preoperatively prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow in patients with end stage renal disease (ESRD).  This is a covered service only when the results of the study are necessary to determine appropriate vessel utilization.  The need for a hemodialysis access site must be determined prior to the performance of the test. For limitations see: CMS Pub 100-02 Medicare Benefit Policy Manual, Chapter 11-End Stage Renal Disease (ESRD), Section 40, H. 

Credentialing and Accreditation Standards
The accuracy of non-invasive vascular diagnostic studies depends on the knowledge, skill, and experience of the technologist and interpreter. Consequently, the physician performing and/or interpreting the study must be capable of demonstrating documented training and experience. A vascular diagnostic study may be personally performed by a physician, a certified technologist, or in a certified vascular testing lab.

Services will be considered medically reasonable and necessary only if performed by appropriately trained providers.

  1. All non-invasive vascular diagnostic studies must be performed meeting at least one of the following:
    1. performed by a licensed qualified physician, or
    2. performed by a technician who is certified in vascular technology, or
    3. performed in facilities with laboratories accredited in vascular technology.
  2. A licensed qualified physician for these services is defined as:
    1. Having trained and acquired expertise within the framework of an accredited residency or fellowship program in the applicable specialty/subspecialty in ultrasound (US) or must reflect equivalent education, training, and expertise endorsed by an academic institution in ultrasound or by applicable specialty/subspecialty society in ultrasound, or
    2. Has the Registered Vascular Technologist (RVT), Registered Physician Vascular Interpretation (RPVI), or ASN: Neuroimaging Subspecialty Certification; and
    3. Is able to provide evidence of proficiency in the performance and interpretation of each type of diagnostic procedure performed.
  3. Nonphysician personnel performing tests must demonstrate basic qualifications to perform tests and have training and proficiency as evidenced by licensure or certification by an appropriate State health or education department.  In the absence of a State licensing board, non-physician personnel must be certified by an appropriate national credentialing body. Appropriate personnel certification includes the American Registry of Diagnostic Medical Sonographers (ARDMS), Registered Vascular Technologist (RVT) credential; or Cardiovascular Credentialing International’s Registered Vascular Specialist (RVS).
  4. Laboratories must be certified by one of the following:
    • Intersocietal Accreditation Commission (IAC),
    • American College of Radiology (ACR),
    • Joint Commission (Vascular lab certification would need to be noted under the main certification either under inpatient or ambulatory care depending on where the test is being performed), or
    • DNV-GL (specific for hospitals only)

    According to which certifying body listed above is selected, that accrediting body’s standards must be followed.

Summary of Evidence

N/A

Analysis of Evidence (Rationale for Determination)

N/A

Proposed Process Information

Synopsis of Changes
Changes Fields Changed
N/A
Associated Information
Sources of Information
Bibliography
Open Meetings
Meeting Date Meeting States Meeting Information
N/A
Contractor Advisory Committee (CAC) Meetings
Meeting Date Meeting States Meeting Information
N/A
MAC Meeting Information URLs
N/A
Proposed LCD Posting Date
Comment Period Start Date
Comment Period End Date
Reason for Proposed LCD
Requestor Information
This request was MAC initiated.
Requestor Name Requestor Letter
N/A
Contact for Comments on Proposed LCD

Coding Information

Bill Type Codes

Code Description
N/A

Revenue Codes

Code Description
N/A

CPT/HCPCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph:

N/A

Group 1 Codes:

N/A

N/A

Additional ICD-10 Information

General Information

Associated Information

Documentation Requirements
Adequate documentation is essential for high-quality patient care and to demonstrate the reasonableness and medical necessity of the study(ies). Documentation must support the criteria as described in the Coverage Indications, Limitations, and/or Medical Necessity section of this LCD. There should be a permanent record of the performed studies and interpretation. The documentation should include a description of the studies performed and any contrast media and/or radiopharmaceuticals used. Any known significant patient reaction or complications should be recorded. Comparison with prior relevant studies needs to be addressed in the documentation along with both normal and abnormal findings. Variations from normal should be documented along with measurements. The report should address or answer any specific clinical questions. If there are factors that prevent answering the clinical questions, this should be explained in the documentation. Retention of the ultrasound examination images should be consistent both with clinical need and with relevant legal and local health care facility requirements.

If the provider of the study is other than the ordering/referring physician/nonphysician practitioner, that provider must maintain a copy of the test results and interpretation, along with copies of the ordering/referring physician/nonphysician practitioner’s order for the studies. This order is required to provide adequate diagnostic information to the performing provider. The physician/nonphysician practitioner must state the clinical indication/medical necessity for the study in his/her order for the test. The provider is responsible for ensuring the medical necessity of procedures and maintaining the medical record, which must be available to Medicare upon request. Results of all testing must be shared with the referring physician. Non-invasive vascular studies are medically reasonable and medically necessary only if the outcomes will be utilized in the clinical management of the patient.

Utilization Guidelines
Each patient’s condition and response to treatment must medically warrant the number of services reported for payment. Medicare requires the medical necessity for each study reported to be clearly documented in the patient’s medical record.

Frequency of follow-up studies will be carefully monitored for medical necessity and it is the responsibility of the physician/provider to maintain documentation of medical necessity in the patient’s medical record.

Generally, it is expected that noninvasive vascular studies would not be performed more than once in a year, excluding inpatient hospital (21) and emergency room (23) places of services.

Only one preoperative scan is considered reasonable and necessary for hemodialysis access site surgery. If a more current preoperative scan is indicated for a patient with multiple comorbidities having difficulty being stabilized for surgery or a change in condition, the medical record would need to support the medical necessity of the second scan.

Only one limited study is considered reasonable and necessary post operatively within 72 hours of a saphenous vein ablation, whether surgery is performed on one side or bilaterally.

Pre-surgical conduit mapping of the radial artery(ies) should only be accompanied by vein-mapping studies when the arterial studies demonstrate a non-acceptable conduit, or an insufficient conduit is available for multiple bypass procedures.

Duplex scanning and physiologic studies may be reimbursed during the same encounter if the physiologic studies are abnormal and/or to evaluate vascular trauma, thromboembolic events or aneurysmal disease. The documentation must support the medical necessity.

Documentation must be provided supporting the need for more than one imaging study Doppler flow or vessel mapping and arteriogram.

Performance of both non-invasive extracranial arterial studies and non-invasive evaluation of extremity veins during the same encounter is not appropriate as a general practice or standing protocol, and therefore, generally would not be expected to be done together. Consequently, documentation must clearly support the medical necessity if both procedures are performed during the same encounter.

Preventive and/or screening services unless covered in Statute are not covered by Medicare.

Sources of Information
N/A
Bibliography

American College of Radiology. ACR-AIUM-SRU Practice Parameter for the Performance of Peripheral Venous Ultrasound Exam. 2014; Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/US-PeriphVenous.pdf. Accessed December 31, 2021.

American College of Radiology. ACR–AIUM–SRU Practice Parameter for the Performance of Ultrasound Vascular Mapping for Preoperative Planning of Dialysis Access. 2014; Available at:
https://www.acr.org/-/media/ACR/Files/Practice-Parameters/US-PreOpDialysis.pdf. Accessed December 31, 2021.

American College of Radiology. ACR-SPR-SRU Practice Parameter for Performing and Interpreting Diagnostic Ultrasound Examinations. 2014; Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/us-perf-interpret.pdf. Accessed December 31, 2021.

American College of Radiology. ACR Practice Parameter for Communication of Diagnostic Imaging Findings. 2014; Available at: https://www.acr.org/-/media/acr/files/practice-parameters/communicationdiag.pdf. Accessed December 31, 2021.

American College of Radiology. ACR-AAPM Technical Standard for Diagnostic Medical Physics Performance Monitoring of Real Time Ultrasound Equipment. 2011; Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/US-Equip.pdf. Accessed December 31, 2021.

American College of Radiology. Ultrasound Accreditation Program Requirements. 2010; https://www.acraccreditation.org/Modalities/Ultrasound. Accessed December 31, 2021.

Allon M, Lockhart ME, Lilly RZ, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney International. 2001;60(5):2013-2020. doi:10.1046/j.1523-1755.2001.00031.x

Erickson CA, Towne JB, et al. Ongoing vascular laboratory surveillance is essential to maximize long-term in situ saphenous vein bypass patency. Journal of Vascular Surgery. 1996;23(1):18-27. doi:10.1016/s0741-5214(05)80031-x

Ferring M, Henderson J, Wilmink A, Smith S. Vascular ultrasound for the pre-operative evaluation prior to arteriovenous fistula formation for haemodialysis: Review of the evidence. Nephrology Dialysis Transplantation. 2008;23(6):1809-1815. doi:10.1093/ndt/gfn001

Gerhard-Herman M, Gardin JM, et al. Guidelines for Noninvasive Vascular Laboratory Testing: A report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. Journal of the American Society of Echocardiography. 2006;19(8):955-972. doi:10.1016/j.echo.2006.04.019

Intersocietal Accreditation Commission. IAC Standards and Guidelines for Vascular Testing Accreditation. 2013. Available at: https://intersocietal.org/iac-standards/. Accessed January 28, 2022.

National Kidney Foundation. KDOQI Clinical Practice Guidelines and Recommendations: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy, Vascular Access. 2006. Available at:
https://www.kidney.org/sites/default/files/docs/12-50-0210_jag_dcp_guidelines-hd_oct06_sectiona_ofc.pdf. Accessed December 31, 2021.

Silva, Jr MB, Hobson II RW, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. Journal of Vascular Surgery. 1998;27(2):302-308. doi:10.1016/s0741-5214(98)70360-x

Teodorescu V, Gustavson S, Schanzer H. Duplex ultrasound evaluation of Hemodialysis Access: A Detailed protocol. International Journal of Nephrology. 2012;2012:1-7. doi:10.1155/2012/508956

Revision History Information

Revision History Date Revision History Number Revision History Explanation Reasons for Change
11/30/2023 R17

Posted 11/30/2023 Review completed 11/08/2023 with no change in coverage.

  • Provider Education/Guidance
  • Other (Review)
01/27/2022 R16

02/01/2022 - Removed and replaced broken link for Intersocietal Accreditation Commission in the bibliography.

  • Typographical Error
01/27/2022 R15

01/27/2022 Clarified information under Credentialing and Accreditation Standards regarding certification as a certified vascular testing lab. Sources of Information and Bibliography updated to correct format. Review completed 12/31/2021.

  • Provider Education/Guidance
  • Other (Review)
07/01/2021 R14

07/01/2021 Review completed 05/28/2021.

  • Other
12/26/2019 R13

Any codes listed in this LCD have been removed to comply with Change Request 10901. Review completed 12/01/2019.

  • Revisions Due To ICD-10-CM Code Changes
  • Other (Compliance with CR 10901)
11/28/2019 R12

11/28/2019 - Change Request 10901 Local Coverage Determinations (LCDs): it will no longer be appropriate to include Current Procedure Terminology (CPT)/Health Care Procedure Coding System (HCPCS) codes or International Classification of Diseases Tenth Revision-Clinical Modification (ICD-10-CM) codes in the LCDs. All CPT/HCPCS, ICD-10 codes, and Billing and Coding Guidelines have been removed from this LCD and placed in Billing and Coding: Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies article linked to this LCD. Consistent with Change Request 10901 language from IOMs and/or regulations has been removed and the applicable manual/regulation has been referenced.

  • Other (Compliance with CR 10901)
10/01/2019 R11

09/26/2019 ICD-10 CM Code Updates: Added the following codes to Group 1: I26.93, I26.94, I80.241, I80.242, I80.243, I80.249, I80.251, I80.252, I80.253, I80.259, I82.451, I82.452, I82.453, I82.459, I82.461, I82.462, I82.463, I82.469, I82.551, I82.552, I82.553, I82.559, I82.561, I82.562, I82.563, and I82.569.

  • Revisions Due To ICD-10-CM Code Changes
10/01/2018 R10

10/01/2018 ICD-10 CM Code Updates: deleted codes T81.4XXA, T81.4XXD and T81.4XXS; and added codes T81.41XA, T81.41XD, T81.41XS, T81.42XA, T81.42XD, T81.42XS, T81.43XA, T81.43XD, T81.43XS, T81.44XA, T81.44XD, T81.44XS, T81.49XA, T81.49XD, and T81.49XS.

  • Revisions Due To ICD-10-CM Code Changes
06/01/2018 R9

06/01/2018 Annual review done 05/02/2018. Formatting changes made. No change in coverage.

  • Other (Annual Review)
10/01/2017 R8

10/01/2017 Added code Z01.810 to Groups 1 and 3 and to Paragraph 3. ICD-10 code updates: description change to Group 1 codes: I82.811, I82.812, I83.811, I83.812, I83.891 and I83.892; and added the following codes to Group 1: L97.115, L97.116, L97.118, L97.125, L97.126, L97.128, L97.215, L97.216, L97.218, L97.225, L97.226, L97.228, L97.315, L97.316, L97.318, L97.325, L97.326, L97.328, L97.415, L97.416, L97.418, L97.425, L97.426, L97.428, L97.515, L97.516, L97.518, L97.525, L97.526, L97.528, L97.815, L97.816, L97.818, L97.825, L97.826, L97.828, L97.915, L97.916, L97.918, L97.925, L97.926, and L97.928. At this time 21st Century Cures Act will apply to new and revised LCDs that restrict coverage which requires comment and notice. This revision is not a restriction to the coverage determination; and, therefore not all the fields included on the LCD are applicable as noted in this policy.

  • Revisions Due To ICD-10-CM Code Changes
  • Other
06/01/2017 R7 06/01/2017 Annual review done 05/03/2017. Typographical errors corrected. Added codes I82.4Y1, I82.4Y2, I82.4Y3, I82.4Z1, I82.4Z2, I82.4Z3, I82.5Y1, I82.5Y2, I82.5Y3, I82.5Z1 I82.5Z2, and I82.5Z3 to Group 1.
  • Revisions Due To ICD-10-CM Code Changes
  • Other ((Annual Review))
01/01/2017 R6 01/01/2017 CPT 2017 code updates, deleted code 93965.

  • Revisions Due To CPT/HCPCS Code Changes
10/01/2016 R5 10/01/2016 ICD-10-CM code updates. Group 1 added codes: I97.620, I97.621, I97.622, I97.630, I97.631, I97.638, I97.640, I97.641, I97.648, T85.818A, T85.868A and T85.898A. Description changed codes: I97.610, I97.611, I97.618, L76.21, L76.22, M96.830, M96.831, T82.817A, T82.818A, T82.858A, T8.2867A and T82.868A. Deleted codes: I97.62, T85.81XA and T85.86XA. Group 2 Description changed codes: T82.818A, T82.828A, T82.838A, T82.848A, T82.858A and T82.868A. Group 3 Description changed codes: T82.818A, T82.828A, T82.838A, T82.848A, T82.858A and T82.868A. Added DNV-GL to the list of accrediting bodies.
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R4 06/01/2016 Annual review completed 05/06/2016. Corrected typos. Added IOM references throughout document and removed unnecessary IOM references. Billing and Coding guideline is removed.
  • Other (Annual Review)
10/01/2015 R3 04/01/2016 Added R06.00 to Group 1 Codes effective 10/01/2015.
  • Other (Other – Added ICD-10 codes)
  • Revisions Due To ICD-10-CM Code Changes
10/01/2015 R2 01/01/2016 Added I80.201, I80.202, I80.203, I82.401, I82.402, I82.403, I82.501, I82.502, I82.503, and Z09 to Group 1 Codes effective 10/01/2015.
  • Other (Other – Added ICD-10 codes)
10/01/2015 R1 12/01/2015 Added the following codes to Group 1 Codes effective 10/01/2015: L53.8, L53.9, L54 and M79.89. Added the following statement to Group 1 Paragraph to clarify the codes with a 7th digit of A, D, or S: For codes in the table below that require a 7th character, letter A initial encounter, D subsequent encounter or S sequela may be used. All 7th digits listed in the Group 1 Codes table are now “A” with the ability to use “D” or “S” when coding the diagnosis. Removed the CAC information.
  • Other (Added ICD-10 codes)
  • Revisions Due To ICD-10-CM Code Changes
N/A

Associated Documents

Attachments
N/A
Public Versions
Updated On Effective Dates Status
11/20/2023 11/30/2023 - N/A Currently in Effect You are here
02/02/2022 01/27/2022 - 11/29/2023 Superseded View
01/19/2022 01/27/2022 - N/A Superseded View
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A

Read the LCD Disclaimer